US edition
How can biosolutions power America's next era of growth?
The US has the resources to lead the next industrial era, and with a modernized policy and regulatory environment, the US can be at the forefront, driving economic growth, jobs, and national competitiveness.
US edition
The next engine of American growth
Biotechnology and biomanufacturing are emerging as key drivers of economic growth, industrial resilience, andglobal competitiveness. The United States is well positioned to lead, but realizing that opportunity will require amodernized policy and regulatory environment that enables innovation and removes scale-up barriers.
The value of biosolutions report outlines how, given the right policies in place, the bioeconomy can generate 84 billion USD in economic value by 2035, up from 34,5 billion USD today, while supporting more than 404,700 direct and indirect jobs nationwide.
Ready to power America's next era of growth with biosolutions?
Biosolutions are on the rise.
Are you ready?
With biosolutions impacting so many industries, they're creating a virtuous cycle of jobs, growth and resilience for a secure and prosperous future.
With the right policies in place, the bioeconomy could generate more than nearly 405,000 jobs across the United States while contributing up to USD 84 billion in economic value by 2035. As biotechnology scales across industries, it can strengthen our economy, create high-quality jobs, and unlock new opportunities for American workers and businesses.
Biotechnology and biomanufacturing are reshaping how products are made, from chemicals and materials to food and medicines. By enabling more efficient production and expanding domestic manufacturing capacity, the bioeconomy can strengthen America's competitive position and help secure leadership in the industries of the future.
The bioeconomy can reduce dependence on vulnerable supply chains by enabling domestic production of critical products and inputs. With the right policy framework, biotechnology can strengthen economic security, enhance resource resilience, and help build a more self-reliant and adaptable industrial base.
Industrial biotech is going to reshape how things are made, and who makes them. The United States has the science and the industrial base to lead — now we need to act.
Partners and supporters
